Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, according to a February 2017 study from The University of Texas MD Anderson Cancer. A release from the center notes that the encouraging research, published in the journal… Continue reading More Patients with Early-Stage Breast Cancer May Not Need Chemo